TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway
Immunity, Inflammation and Disease · 2023
DOI: 10.1002/iid3.796 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Qiuli Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, Fujian, P. R. China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Thyroid Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Thyroid cancer has received increasing attention; however, its detailed pathogenesis and pathological processes remain unclear. We investigated the role of TANK‐binding kinase 1 (TBK1) in the progression of thyroid cancer.
Methods
The expression of TBK1 in thyroid cancer and normal control tissues was analyzed using real‐time quantitative polymerase chain reaction. The function of TBK1 on thyroid cancer cells was detected using MTT, colony formation, wound healing, and Transwell assays. The xenograft assay was carried out to check on the role of TBK1 in thyroid cancer.
Results
TBK1 was highly expressed in thyroid tumors. High expression of TBK1 raised viability, proliferation, migration, and invasion of thyroid cancer cells. Gene set enrichment analysis revealed that TBK1 activated the phosphatidylinositol‐3‐kinase/protein kinase B/mammalian target of rapamycin pathway. In addition, Myc‐associated zinc finger protein (MAZ) was overexpressed in thyroid cancer and transcriptionally activated BK1. MAZ silence reversed the effects of TBK1 overexpression on thyroid cancer progression. Cotransfection with MAZ small‐interfering RNA(siRNA) and TBK1 siRNA did not strengthen the inhibitory effect of TBK1 silencing on the thyroid cancer cells. The xenograft tumor assay showed that TBK1 short hairpinRNA inhibited tumor growth.
Conclusion
MAZ silencing inhibited tumor progress of thyroid cancer cells, whereas this inhibitory effect was reversed by TBK1 overexpression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, Fujian, P. R. China.
ORCID-Profile: Huadong Lu
Zitieren
APA
Jiang, Q., Guan, Y., Zheng, J., & Lu, H. (2023). TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.796
Vancouver
Jiang Q, Guan Y, Zheng J, Lu H. TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.796
BibTeX
@article{Jiang2023,
author = {Jiang, Qiuli and Guan, Yingying and Zheng, Jingmei and Lu, Huadong},
title = {TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway},
journal = {Immunity, Inflammation and Disease},
year = {2023},
doi = {10.1002/iid3.796}
}
EUVIMED